Drug Landscape ›
vitamin B6 ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 8,434
Most-reported reactions
Fatigue — 1,257 reports (14.9%) Nausea — 1,090 reports (12.92%) Diarrhoea — 990 reports (11.74%) Off Label Use — 892 reports (10.58%) Drug Ineffective — 849 reports (10.07%) Dyspnoea — 696 reports (8.25%) Vomiting — 677 reports (8.03%) Pain — 668 reports (7.92%) Asthenia — 660 reports (7.83%) Dizziness — 655 reports (7.77%)
Source database →
vitamin B6 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is vitamin B6 approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for vitamin B6 in United States?
The First People's Hospital of Huzhou is the originator. The local marketing authorisation holder may differ — check the official source linked above.